This site is intended for healthcare professionals only
LoginRegister
Lupin receives positive EMA comittee opinion for eye therapy RanluspecLupin divests US Commercial Women Health Specialty Business to Evofem Biosciences for nearly USD 84...
Takeda announces closing of partnership with Innovent Biologics for oncology medicinesSubmit Separate Retrospective, Prospective Study data of subjects: CDSCO Panel Tells Takeda on...
Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance FailuresCasper Pharma gets 2 USFDA observations
USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three ObservationsUSFDA successfully concludes inspection at Piramal Pharma Ahmedabad facility
Novartis concludes acquisition of Tourmaline BioCDSCO Panel approves Novartis Healthcare for selective use of Secukinumab dose up to 300 mg
Johnson and Johnson Agrees to Cut US Drug Prices in Deal with Trump Administration to Avoid TariffsCDSCO Panel Approves Johnson and Johnson's Protocol Amendment Proposal to study anti-cancer drug...
Johnson and Johnson Agrees to Cut US Drug Prices in Deal with Trump Administration to Avoid TariffsJnJ strengthens atopic dermatitis pipeline with acquisition of Yellow Jersey Therapeutics
Pfizer Slapped With Rs 8.79 Cr GST Demand Over Alleged ITC Irregularities, Plans AppealPfizer advances development of once-daily formulation of Oral GLP-1 Receptor Agonist Danuglipron
JnJ completes acquisition of Halda Therapeutics, its novel platform for cancer treatmentMerck completes acquisition of EyeBio
Intas PharmaIntas Pharmaceuticals Gets CDSCO Panel Nod for Palatability Study of Temozolomide powder for oral...
DMER Releases Pharmacist, Lab Technician CBT Results 2025Several pharma, Indian research companies under scanner for faking generic Viagra data for FDA...
Cipla Names Arun Kakatkar as Global Chief People OfficerUSFDA classifies inspection at Cipla Kurkumbh facility as VAI
X